VivoSim Labs (VIVS) Balance Sheet: Assets & Liabilities

VivoSim Labs (VIVS) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2026), VivoSim Labs reported total assets of $7.39M and total liabilities of $8.48M. Shareholders' equity was negative at −$1.10M, meaning liabilities exceed assets. Total debt stood at $447.00K against $5.02M in cash and short-term investments, a net cash position of $4.58M.

VivoSim Labs Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for VivoSim Labs, Inc. (VIVS) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2019	Mar 2017
Current Assets
Cash and Cash Equivalents	5.02	11.31	2.90	28.68	28.68	27.36	36.48	62.75
Short-Term Investments	0.00	0.00	0.71	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	5.02	11.31	2.90	28.68	28.68	27.36	36.48	62.75
Accounts Receivable	1.05	0.03	0.03	0.00	0.00	0.11	0.56	0.65
Inventory	0.00	0.00	0.30	0.00	0.00	0.00	0.49	0.55
Other Current Assets	0.56	0.79	0.71	0.86	0.86	0.85	1.05	1.14
Total Current Assets	6.63	12.13	3.94	29.53	29.53	28.32	38.57	65.09
Non-Current Assets
Property, Plant & Equipment (Net)	0.61	1.29	1.97	2.82	2.82	0.00	1.83	3.84
Intangible Assets	0.00	0.00	0.01	0.00	0.09	0.00	0.00	0.00
Other Non-Current Assets	0.15	1.23	0.45	0.95	0.95	0.12	0.22	0.25
Total Non-Current Assets	0.76	2.52	2.41	3.76	3.76	0.12	2.05	4.09
Total Assets	7.39	14.65	6.35	33.30	33.30	28.44	40.62	69.18
Current Liabilities
Accounts Payable	1.02	1.64	0.63	0.42	0.42	0.72	0.63	1.17
Short-Term Debt	0.45	0.52	0.49	0.48	0.00	0.00	0.00	0.00
Accrued Liabilities	0.56	0.57	0.73	2.85	0.06	0.44	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.53	0.58
Other Current Liabilities	1.32	1.57	2.85	0.49	0.44	1.09	2.58	4.26
Total Current Liabilities	2.79	3.74	1.86	1.38	1.38	1.81	3.74	6.01
Non-Current Liabilities
Long-Term Debt	0.00	0.42	0.89	1.70	1.70	0.00	0.00	0.00
Other Non-Current Liabilities	5.70	0.00	0.00	0.00	0.00	0.00	0.59	0.75
Total Non-Current Liabilities	5.70	0.42	0.89	1.70	1.70	0.00	0.59	0.81
Total Liabilities	8.49	4.16	2.75	3.09	3.09	1.81	4.33	6.82
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.01	0.01	0.01	0.12	0.10
Retained Earnings	-356.00	-342.16	-339.67	-307.74	-307.74	-279.47	-260.76	-199.32
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01
Treasury Stock	-	0.00	0.00	0.00	0.00	-	-	-
Additional Paid-in Capital	354.90	352.65	343.27	340.32	337.94	335.48	296.93	261.59
Shares Outstanding	2.89	1.90	0.84	0.73	0.73	-	-	-
Total Stockholders' Equity	-1.10	10.49	3.60	30.21	30.21	26.63	36.30	62.36
Total Liabilities & Equity	7.39	14.65	6.35	20.31	33.30	39.92	40.62	69.18

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About VivoSim Labs Balance Sheet

How much debt does VivoSim Labs have?

VivoSim Labs had total debt of $447.00K as of Mar 31, 2026, against $5.02M in cash and short-term investments. Total debt was $942.00K a year earlier.

What are VivoSim Labs's total assets?

VivoSim Labs reported total assets of $7.39M as of Mar 31, 2026, down 49.6% from $14.65M a year earlier. Total liabilities were $8.48M.

What is VivoSim Labs's shareholders' equity?

VivoSim Labs's shareholders' equity was negative at −$1.10M as of Mar 31, 2026, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition